EquityZen Growth Technology Fund LLC - Series 2042
Raised
$283K
Investors
27
Min Invest
$9,997
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2042 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Phil Haslett. The fund raised $283K from 27 investors with a $10K minimum investment under Rule 506(b) and 3(c)(1) exemptions. It is part of the EquityZen platform, which operates 1889 pre-IPO investment vehicles.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption structure common to EquityZen's series vehicle platform. The $10K minimum investment reflects the retail-accessible tier typical of syndicated pre-IPO access platforms, positioning it below the $50K+ thresholds seen in institutional or direct secondary funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
